Gabapentin, prescribed for chronic pain, may raise dementia risk by up to 40%, according to a U.S. study. Younger adults (35–49) faced double the risk with long-term use. The drug alters GABA neurotransmitters, possibly triggering cognitive decline. Though causation is debated, the correlation is alarming. Despite these warnings, prescriptions remain high—raising serious questions about Big Pharma’s safety standards and long-term drug impacts.
More Information from Natural News